8156 — Sinopharm Tech Holdings Balance Sheet
0.000.00%
Last trade - 00:00- HK$117.23m
- HK$263.19m
- HK$41.28m
- 20
- 23
- 86
- 37
Annual balance sheet for Sinopharm Tech Holdings, fiscal year end - June 30th, HKD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 6.75 | 7.48 | 2.99 | 1.78 | 2.64 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 34.2 | 26.6 | 42.4 | 22.9 | 28.6 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 62.1 | 49.6 | 48.1 | 27 | 38.1 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 37.8 | 28.3 | 5.19 | 1.16 | 3.88 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Total Assets | 188 | 136 | 76.9 | 33.5 | 44.5 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 254 | 273 | 250 | 213 | 249 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Liabilities | 261 | 275 | 244 | 206 | 244 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -73.1 | -139 | -167 | -173 | -199 |
| Total Liabilities & Shareholders' Equity | 188 | 136 | 76.9 | 33.5 | 44.5 |
| Total Common Shares Outstanding |